Catheter Precision Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Net Income	-71.37	-26.87	-25.07	-36.05	-56.96	-30.83	-17.77	-4.2
Depreciation & Amortization	2.08	0.42	1.57	2.37	1.75	0.62	0.22	0.1
Share-Based Compensation	1.22	0.45	2.24	4.08	23.54	14.73	12.71	2.3
Other Operating Activities	46.66	3.43	-6.36	1.29	-1.51	-3.03	-0.68	-0.08
Operating Cash Flow	-20.62	-22.57	-27.63	-28.3	-33.17	-18.51	-5.52	-1.89
Capital Expenditures	-0.08	0.02	0.33	-0.07	-0.27	-0.58	-0.55	-0.21
Acquisitions	0.02	0	3.47	0	0	0	0	0
Change in Investments	0	0	0	16	-15.76	0	0	0
Investing Cash Flow	-0.06	0.02	3.8	15.93	-16.03	-0.58	-0.55	-0.21
Share Issuance / Repurchase	9.56	23.92	15.15	19.94	0.04	75.25	10.43	5.27
Debt Issued / Paid	-0.36	0	-0.27	1.71	-0.34	-0.08	-0.04	0.11
Other Financing Activities	-0.82	-0.56	0.07	0.04	-0.23	-	-	-
Financing Cash Flow	8.39	23.36	14.96	21.69	-0.53	75.17	10.39	5.37
Net Cash Flow	-12.29	0.81	-8.86	9.32	-49.73	56.08	4.32	3.28
Free Cash Flow	-20.7	-22.55	-27.3	-28.37	-33.44	-19.09	-6.07	-2.1
Free Cash Flow Margin	-4682.13%	-161050.00%	-124072.73%	-10954.05%	-464.52%	-305.10%	-103.41%	-35.07%
Free Cash Flow Per Share	-3.77	-21.81	-270.26	-834.93	-3178.80	-2585.32	-1005.63	-376.91

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).